Vascular grafts and endovascular aortic stent grafts

A vascular graft is an implanted device that repairs, replaces or bypasses part of a blood vessel. MeSH describes the device as made of synthetic or biological material and used to repair injured or diseased vessels. The US regulator's regulation says the graft is meant for vessels other than the coronary or cerebral ones, and it also names provision of vascular access. The US regulator lists a separate product type for endovascular grafts used to treat aortic aneurysm, and one approval record, for a delivery system of limb-extension stent grafts, says the endovascular system it accompanies is indicated for endovascular treatment in patients with AAA. The sources read do not define a stent graft, describe how it is placed or report outcomes.

Also called Vascular graft · Vascular graft prosthesis · Blood vessel prosthesis · Aortic stent graft · Endovascular aortic stent graft

  • Technology
  • In this atlas

Overview

Technical summary

MeSH D001807 (Blood Vessel Prosthesis), broad: the page also covers endovascular aortic stent grafts. 21 CFR 870.3450 (vascular graft prosthesis) is class II with special controls. The US regulator product code MIH, System, Endovascular Graft, Aortic Aneurysm Treatment, is device class 3. The only product-specific text read is the openFDA record of supplement S038 to premarket approval P040002, a supplement for a stand-alone delivery system of limb-extension stent grafts; it is used only to show how the US regulator words the indication, and the sources do not spell out the abbreviation AAA. No outcome, complication, sizing or durability data are recorded.

How it works

A vascular graft is an implanted device that repairs, replaces or bypasses sections of native or artificial vessels (21 CFR 870.3450). An endovascular graft for the aorta is a separate product type in the US regulator's classification, for treating aortic aneurysm; the sources read do not describe its design.

Classification codes

  • MeSH id.nlm.nih.gov linked data, retrieved 2026-11-08 D001807
  • FDA product code openFDA device classification endpoint, retrieved 2026-11-08 (dataset last updated 2026-10-26) MIH System, Endovascular Graft, Aortic Aneurysm Treatment
  • 21 CFR 21 CFR 870.3450

Strengths

  • The US regulator's regulation lists the purposes of a vascular graft prosthesis: to repair, replace or bypass vessel sections, and to provide vascular access.
  • One approval record, for a stand-alone delivery system of limb-extension stent grafts, says the endovascular system it accompanies is indicated for endovascular treatment in patients with AAA.

Limitations

  • The regulation excludes coronary and cerebral vessels, so it does not describe grafts used there.
  • The product-specific record is a supplement for one manufacturer's stand-alone delivery system. It shows the indication wording only, not performance.
  • No source read reports outcomes or complications, so no benefit or harm figure is given.

Required infrastructure

  • A procedure to implant the device. The sources read do not describe who performs it, the access route or follow-up imaging.

Claims and evidence

No claims are published for this technology yet.

Record details

Record id
cardio:vascular-grafts-and-endovascular-aortic-stent-grafts
Content hash
bd6e250f325b5ec46080d677b03bc8606c9126c4a799bfac875f5a21006ee5bb